Product Information
OXAZEPAM 30 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $1.2342 per EA under NDC 69315091301. Its NADAC has been published 52 times since Aug 27, 2025.
FDA first approved this application on Mar 3, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315091301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA218261FDA Approved
3/3/2025
TE Code
AB
On Market Since
7/9/2025
Pharmacological Classes
Price Statistics
The NADAC for OXAZEPAM 30 MG CAPSULE has been published 52 times since Aug 27, 2025, and over the history we have for it it has declined 9.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2342 per EA |
|---|---|
| All-time high | $1.3640 (Sep 10, 2025) |
| All-time low | $1.1218 (May 20, 2026) |
| 52-week high | $1.3640 |
| 52-week low | $1.1218 |
| Median price | $1.2292 |
| Average price | $1.2269 |
| Largest weekly change | -5.1% (Mar 18, 2026) |
| Weeks tracked | 52 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OXAZEPAM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXAZEPAM 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OXAZEPAM 30 MG CAPSULE, manufactured by Leading Pharma, LLC, is $1.2342 per EA (NDC 69315091301), effective Aug 19, 2026.
How has the price of OXAZEPAM 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OXAZEPAM 30 MG CAPSULE has declined 9.5%. It has been tracked across 52 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for OXAZEPAM 30 MG CAPSULE?
Since Aug 27, 2025, the NADAC for OXAZEPAM 30 MG CAPSULE has ranged from a low of $1.1218 (May 20, 2026) to a high of $1.3640 (Sep 10, 2025), with a median of $1.2292 per EA.
Are there cheaper alternatives to OXAZEPAM 30 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of OXAZEPAM 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OXAZEPAM 30 MG CAPSULE?
OXAZEPAM 30 MG CAPSULE (NDC 69315091301) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.